Hyperlipidemia

• FDA label_change · 2007-05-16
  FDA Approved: VYTORIN — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.

• FDA label_change · 2006-08-28
  FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin from Prasco Laboratories, resulting in…